TAMPA, FL
4 risk indicators measuring financial stability and operational resilience
Sign in with your work email to view Tuckman-Chang indicators
Sign In — Free (10 views/day)INTERNATIONAL SOCIETY FOR PHARMACEUTICAL ENGINEERING INC, founded in 1980, is a mid-sized nonprofit that reported $17.3M in total revenue in fiscal year 2024. Revenue decreased 6% compared to the prior year.
ISPE IS THE GLOBAL INDUSTRY LEADER IN CONNECTING PHARMACEUTICAL KNOWLEDGE TO DELIVER MANUFACTURING AND SUPPLY CHAIN INNOVATION, OPERATIONAL EXCELLENCE, AND REGULATORY INSIGHTS TO ENHANCE INDUSTRY EFFORTS TO DEVELOP, MANUFACTURE AND RELIABLY DELIVER QUALITY MEDICINES TO PATIENTS.
PROFESSIONAL DEVELOPMENT CONSISTS PRIMARILY OF CONFERENCES AND TRAINING COURSES TO KEEP INDUSTRY PROFESSIONALS INFORMED OF THE LATEST TECHNOLOGICAL AND REGULATORY TRENDS AND TO HELP THE...
PROFESSIONAL DEVELOPMENT CONSISTS PRIMARILY OF CONFERENCES AND TRAINING COURSES TO KEEP INDUSTRY PROFESSIONALS INFORMED OF THE LATEST TECHNOLOGICAL AND REGULATORY TRENDS AND TO HELP THE PHARMACEUTICAL MANUFACTURING PROFESSION AS A WHOLE TO ENSURE THE SAFETY OF THE WORLD'S SUPPLY OF MEDICINES.
MEMBERSHIP DUES INCLUDE COMMUNICATION OF BENEFITS TO MEMBERS, SUPPORT BY MEMBER SERVICES, AND MANAGEMENT AND OVERSIGHT OF THE ISPE CHAPTERS AND AFFILIATES. PROGRAMS INCLUDE WOMEN IN PHARMA, EMERGING...
MEMBERSHIP DUES INCLUDE COMMUNICATION OF BENEFITS TO MEMBERS, SUPPORT BY MEMBER SERVICES, AND MANAGEMENT AND OVERSIGHT OF THE ISPE CHAPTERS AND AFFILIATES. PROGRAMS INCLUDE WOMEN IN PHARMA, EMERGING LEADERS, AND FACILITY OF THE YEAR AWARDS.
PUBLICATIONS INCLUDE SUBSCRIPTIONS AND ARTICLE REPRINTS PROVIDING THE MOST UP-TO-DATE INFORMATION ON THE LATEST TECHNOLOGICAL AND REGULATORY TRENDS IN THE PHARMACEUTICAL MANUFACTURING INDUSTRY...
PUBLICATIONS INCLUDE SUBSCRIPTIONS AND ARTICLE REPRINTS PROVIDING THE MOST UP-TO-DATE INFORMATION ON THE LATEST TECHNOLOGICAL AND REGULATORY TRENDS IN THE PHARMACEUTICAL MANUFACTURING INDUSTRY. MEMBERS RECEIVE A SUBSCRIPTION TO THE PHARMACEUTICAL ENGINEERING MAGAZINE, WHICH PROVIDES A COMPREHENSIVE SELECTION OF PRACTICAL APPLICATION ARTICLES AND INFORMATION OF IMPORTANCE TO THE INDUSTRY AND MEMBERSHIP. GUIDANCE DOCUMENTS INCLUDE THE DEVELOPMENT AND PUBLISHING OF GUIDANCE INFORMATION INCLUDING BEST PRACTICES AND INNOVATIVE AND EFFECTIVE SOLUTIONS TO INDUSTRY CHALLENGES.
Financial Health Score (300–850) · Liquidity · Solvency · Sustainability · Efficiency
Sign in to view Trantor Score and financial metrics
Liquidity (40%) • Solvency (30%) • Sustainability (20%) • Efficiency (10%)
Sign In — Free (10 views/day)| 2024 | 2023 | Change | |
|---|---|---|---|
| Revenue | $17,304,843 | $18,333,665 | -0.1% |
| Expenses | $17,793,514 | $17,091,709 | +0.0% |
| Net Income | $-488,671 | $1,241,956 | -1.4% |
Comprehensive financial analysis: Altman Z-Score, liquidity, solvency, sustainability, efficiency, and growth metrics
Financial Distress Indicator
Liquidity & Cash Position
Sign in to view all financial metrics
Altman Z-Score • Liquidity Ratios • Solvency Analysis • Growth Indicators • Efficiency Metrics
Sign In| Name | Title | Hours/Week | Role | Reportable Comp | Other Comp | Total |
|---|---|---|---|---|---|---|
| THOMAS HARTMAN | PRESIDENT & CEO (OUTGOING 2024) | 40.00 |
Officer
|
$375,183 | $22,038 | $397,221 |
| MARK HERNICK | CHIEF FINANCIAL & OPERATING OFFICER | 40.00 |
Officer
|
$289,654 | $27,203 | $316,857 |
| JESSICA BLEESS | VP, CONFERENCES & DIGITAL ENGAGEMENT | 40.00 |
Key Emp
|
$189,489 | $12,309 | $201,798 |
| CLIFTON DUNHAM | SR. DIRECTOR, BUSINESS DEVELOPMENT | 40.00 |
Highest
|
$188,579 | $11,983 | $200,562 |
| PHILIP LIPNICK | DIRECTOR, INFORMATION TECHNOLOGY | 40.00 |
Highest
|
$165,318 | $18,276 | $183,594 |
| TORI JOHNSON | DIRECTOR, DEVELOPMENT & FOUNDATION OPERATIONS | 0.00 |
Highest
|
$159,306 | $20,307 | $179,613 |
| JESSICA HARDY | SR. DIRECTOR, MEMBERSHIP & CHAPTER RELATIONS | 40.00 |
Highest
|
$148,462 | $25,761 | $174,223 |
| ROCHELLE MAY | SR. DIRECTOR, PUBLICATIONS | 40.00 |
Highest
|
$142,117 | $25,219 | $167,336 |
| MICHAEL RUTHERFORD | INTERIM CEO | 40.00 |
Officer
|
$100,000 | $0 | $100,000 |
| JEFF BISKUP PE | CHAIR | 1.00 |
Officer
Director
|
$0 | $0 | $0 |
| SCOTT BILLMAN | IMMEDIATE PAST CHAIR | 1.00 |
Officer
Director
|
$0 | $0 | $0 |
| VIVIANNE ARENCIBIA | VICE CHAIR | 1.00 |
Officer
Director
|
$0 | $0 | $0 |
| MICHAEL MARTIN | SECRETARY | 1.00 |
Officer
Director
|
$0 | $0 | $0 |
| YLVA EK | TREASURER | 1.00 |
Officer
Director
|
$0 | $0 | $0 |
| NINA CAUCHON PHD | DIRECTOR (OUTGOING 2024) | 1.00 |
Director
|
$0 | $0 | $0 |
| DAVID CHURCHWARD | DIRECTOR | 1.00 |
Director
|
$0 | $0 | $0 |
| LIZ DOOLEY MSC | DIRECTOR | 1.00 |
Director
|
$0 | $0 | $0 |
| NORMAN GOLDSCHMIDT | DIRECTOR | 1.00 |
Director
|
$0 | $0 | $0 |
| JAMES GRUNWALD | DIRECTOR (INCOMING 2024) | 1.00 |
Director
|
$0 | $0 | $0 |
| SHANSHAN LIU | DIRECTOR (INCOMING 2024) | 1.00 |
Director
|
$0 | $0 | $0 |
| SARAH MIKSINSKI | DIRECTOR | 1.00 |
Director
|
$0 | $0 | $0 |
| TERESA MINERO | DIRECTOR (OUTGOING 2024) | 1.00 |
Director
|
$0 | $0 | $0 |
| VIVIEN SANTILLAN | DIRECTOR (INCOMING 2024) | 1.00 |
Director
|
$0 | $0 | $0 |
| GEORG SINGEWALD PHD | DIRECTOR | 1.00 |
Director
|
$0 | $0 | $0 |
| HIROFUMI SUZUKI | DIRECTOR (OUTGOING 2024) | 1.00 |
Director
|
$0 | $0 | $0 |
| TIM WATSON PHD | DIRECTOR | 1.00 |
Director
|
$0 | $0 | $0 |
| Year | Revenue | Expenses | Assets | Net Income |
|---|---|---|---|---|
| 2024 | $17,304,843 | $17,793,514 | $16,930,698 | $-488,671 |
| 2023 | $18,333,665 | $17,091,709 | $17,990,571 | $1,241,956 |
| 2022 | $15,080,135 | $13,532,053 | $16,259,417 | $1,548,082 |
| 2021 | $10,779,198 | $10,756,916 | $11,781,437 | $22,282 |
| 2020 | $9,646,395 | $9,893,705 | $10,682,582 | $-247,310 |
| 2019 | $14,236,345 | $13,558,113 | $12,426,015 | $678,232 |
| 2018 | $12,739,970 | $12,604,240 | $10,235,966 | $135,730 |
Compare INTERNATIONAL SOCIETY FOR PHARMACEUTICAL ENGINEERING INC with other nonprofits in Florida and across the country.